331
Participants
Start Date
May 31, 2006
Primary Completion Date
November 30, 2007
Study Completion Date
November 30, 2007
Intravenous Diclofenac (DIC075V)
Intravenous Diclofenac (DIC075V): 1 of 2 dosage levels
Intravenous Ketorolac
Intravenous Ketorolac
placebo
placebo
Duke University Medical Center, Durham
Visions Clinical Research, Boynton Beach
Alabama Clinical Therapeutics, Birmingham
Eliza Coffee Memorial Hospital, Florence
Helen Keller Hospital, Sheffield
Drug Research and Analysis Corp., Montgomery
Clinical Research Services, Bismarck
Teton Research / Parkview Surgical, Little Rock
Memorial Hermann Healthcare System - Memorial City Hospital, Houston
Clinical Research Center, San Marcos
Clinical Research Center, Austin
Jean Brown Research, Salt Lake City
Glendale Adventist Medical Center, Glendale
Saddleback Memorial Medical Center, Laguna Hills
Lead Sponsor
Javelin Pharmaceuticals
INDUSTRY